Background: Systemic low-grade inflammation (SLGI), as assessed by measurements of high-sensitivity C-reactive protein (hs-CRP), is a strong independent risk factor for cardiovascular diseases (CVD). Although individuals with hs-CRP ≤1 mg/L have been defined as being at low risk according to AHA/CDC guidelines, the value of very low hs-CRP levels (＜0.5 mg/L) for public health practices is unclear.
INTRODUCTION
Systemic low-grade inflammation (SLGI), as assessed by measuring serum concentrations of high-sensitivity C-reactive protein (hs-CRP), has been found to be an independent risk factor of future cardiovascular events [1] .
Greater understanding of the relationship between SLGI and lifestyle factors would be useful in designing active lifestyle modifications that not only increase the wellness of the general population, but also prevent chronic diseases by reversing epigenetic mechanisms [2] .
Primary prevention consists of health promotion and specific protection. Primary prevention should be a major goal of modern medicine, not only for cardiovascular diseases (CVD), but also for other chronic diseases, such as cancer and neurodegenerative diseases. The identification of population-and individual-level causes of CVD [3, 4] has contributed to a 50% reduction in the mortality rate from coronary heart disease (CHD) between 1980 and 2000. This is
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MATERIALS AND METHODS
This study was approved by the local ethics committee.
Written informed consent was obtained from all the participants prior to screening, and a detailed explanation of the study was provided. The study was conducted according to the principles of the Declaration of Helsinki for biomedical research involving human subjects and the Guideline for Good Clinical Practice.
Exclusion criteria
Subjects were excluded from this study if they had (1) hypertension ( 
Biomarkers
Venous blood samples were collected after a 12 h fast.
Total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), and triglycerides (TG) were assayed by routine laboratory methods, while glucose, insulin, and HbA1c were measured using the Hitachi-7600 analyzer (Hitachi Ltd., Tokyo, Japan).
The concentrations of apoB, apoA1, and hs-CRP were measured by turbidometry and ELISA methods. The homeostasis model assessment of insulin resistance (HOMA-IR) was defined as the product of fasting plasma insulin (μU/mL) and glucose (mg/dL) divided by 405. Aspartate aminotransferase (AST), alanine aminotransferase (ALT), gamma-glutamyl transferase (GGT), albumin, blood urea nitrogen (BUN), and creatinine were measured using an autoanalyzer (Variant, Bio-Rad, Hercules, CA, USA).
Statistical analysis
Data is expressed as mean ± standard deviation (SD) or 
RESULSTS
Of the 104 initially recruited subjects, 16 were excluded, 
DISCUSSION
We observed significantly higher BMI, WC, TG, apoB, visceral fat, VSR, creatinine, uric acid, GGT, and WHR (BIA) In conclusion, we found a significant association between SLGI and indices of central obesity in healthy middle-aged Koreans. Although causality could not be established, these findings suggest the need for chronic disease prevention programs, employing very low levels of hs-CRP as a marker of wellness.
